TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OKUR

OnKure Therapeutics, Inc.

Healthcare · Biotechnology

2.60$ +0.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

OnKure Therapeutics, Inc. (OKUR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 179 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OKUR
Line item Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 148 130 36 25 25 78 115 100 86 73 62 199 179
– 146 129 34 23 24 77 113 98 85 72 61 197 178
– 9.1 12 30 19 19 61 111 97 83 70 59 192 167
– 143 126 30 19 19 77 111 97 83 70 59 192 176
– – – – – 2.0 – – – – – – – –
– 16 15 138 136 149 3.6 11 9.2 7.9 6.4 5.9 14 7.2
– 14 14 7.3 5.6 13 3.2 11 8.8 7.6 6.2 5.9 14 6.6
– 0.3 0.3 0.2 0.2 0.2 0.3 0.5 0.5 0.6 0.6 0.5 0.4 0.3
– 1.8 2.5 3.4 3.6 8.3 0.2 3.0 2.3 2.4 1.3 1.4 11 2.0
– – – – – 5.9 – – – – – – – –
– 133 115 -102 -111 -124 74 104 91 78 66 56 184 172
– -171 -191 -102 -112 -126 -236 -155 -171 -186 -201 -214 -229 -245
13 13 13 13 13 13 13 13 13 14 14 14 14 50

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?